Skip to main content
. Author manuscript; available in PMC: 2015 Sep 15.
Published in final edited form as: J Neuroimmunol. 2014 Jun 27;274(0):168–173. doi: 10.1016/j.jneuroim.2014.06.017

Fig. 3.

Fig. 3

Variations of the serum Aβ1-15 antibody levels in patients carrying different ApoE gene alleles (A) and ANKK1/DRD2 gene alleles (B). A. The serum Aβ1-15 antibodies were tend to be lower in E4/E4 carrying patients in both AD and NC groups although statistically significant could not be reached in the present number of patients compared with the other alleles (p =0.09). B. The levels of Ap1-15 antibodies were tend to be lower in ANKK1 gene CC allele than A1 (CT or TT) allele patietennts (p = 0.11 and 0.39 in AD and NC group).